Reversing myeloid-derived suppressor cells mediated immunosuppression via p38α inhibition enhances immunotherapy efficacy
Direct links to NCBI, no account and no request form: the whole study as GSE228550_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 12 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA950332 and SRA study SRP430118. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
4 replicated groups read from 12 sample titles; they account for 12 of them. Check it against the sample list below before relying on it.
- GSM7123878 MDA-MB-231_DMSO_rep1
- GSM7123879 MDA-MB-231_DMSO_rep2
- GSM7123880 MDA-MB-231_DMSO_rep3
- GSM7123881 MDA-MB-231_Ponatinib_rep1
- GSM7123882 MDA-MB-231_Ponatinib_rep2
- GSM7123883 MDA-MB-231_Ponatinib_rep3
- GSM7123884 4T1_DMSO_rep1
- GSM7123885 4T1_DMSO_rep2
- GSM7123886 4T1_DMSO_rep3
- GSM7123887 4T1_Ponatinib_rep1
- GSM7123888 4T1_Ponatinib_rep2
- GSM7123889 4T1_Ponatinib_rep3
- GSE316054 Targeting the ADAR1 p150 isoform triggers tumor growth inhibition and antitumor immunity to overcome immunotherapy resistance 52 samples
- GSE304029 BRD2 Bromodomain-Mediated Regulation of Cell State Plasticity Modulates Therapy Response in Glioblastoma 56 samples
- GSE299215 E7386 enhances lenvatinib’s antitumor activity in preclinical models and human hepatocellular carcinoma. 44 samples
- GSE312096 Inhibition of PAK2 in endothelial cells suppresses tumor angiogenesis and promotes immune sensitization through CXCL10 24 samples
- GSE271616 A STAT5B-driven mouse model of hepatosplenic γδ T cell lymphoma reveals therapeutic efficacy of JAK inhibitors 23 samples
- GSE282369 Metformin enhances human oligodendrocyte function by altering metabolism 17 samples
- GSE228957 Single-cell or nucleus RNAseq of neuroblastoma patient-derived xenografts 17 samples
- GSE293910 Identification of fibroblast-derived sFRP2 as a new therapeutic target and engineering of siRNA therapies for uterine scarring 12 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.